Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999051750> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2999051750 abstract "ABSTRACT Background The circulating MDSCs and Tregs in cancer patients suppress immune system. This study is investigating the expression of the MDSCs and Tregs in the peripheral blood of NSCLC patients and their correlation with the clinical outcome of the 1st line chemotherapy. Methods 62 chemotherapy naive patients (57 males) with stage IIIB/ IV NSCLC have been enrolled in this study, so far; median age 67. Peripheral blood was collected prior to treatment. 19 healthy, aged-matched donors (12 males) were used as controls. The distinct MDSC subpopulations [A (monocytic): CD11b+CD14+CD15-CD33+CD13+IL-4R+Linlow/-HLA-DR-; B (monocytic): CD11b+CD14+CD15+CD33+CD13+IL-4R+Linlow/-HLA-DR- and C (granulocytic): CD11b+CD14-CD15+CD33+ CD13+IL-4R+)], CD4+ Tregs (CD4+CD25+high CD127low FoxP3+CD39+CD13+) and CD8+ Tregs (CD3+CD8+CD25+ CD45RO+CD13+CCR7+FoxP3+CD39+) were determined by using flow cytometry. A comparison of the overall survival (OS) and the progression-free survival (PFS) according to the frequency of the MDSC and Tregs was performed (high expression defined as the percentage of cells above the 75% percentile of the controls). Results The levels of Tregs prior to treatment did not differ from the controls'. Patients with progression (PD) during the 1st line treatment had significantly elevated percentage of CD4+ (24.6 ± 8.5) and CD8+ (0.7± 0.2) Tregs at baseline compared to those with no PD (3.7± 1.8, p = 0.04; 0.1± 0.05, p= 0.03, respectively). In contrast, MDSCs were significantly increased (A: 3.8 ±0.7; β: 2.5 ± 0.5 and C: 10.8 ± 2.3) in patients compared to controls (0.8 ± 0.4, p = 0.001; 0.5 ± 0.2, p= 0.01, and 2.7 ± 1.3, p= 0.05, respectively) but that difference was not associated with response to treatment. Patients with normal CD8+ Tregs levels at baseline had higher OS and PFS compared to those with high levels (13.2 mo vs 7.9 mo, p= 0.02 and 13.1 mo vs 3.7 mo, p= 0.003, respectively). Conclusion The MDSCs are elevated in NSCLC. The increased expression of CD4+ καi CD8+ Tregs negatively correlated with the treatment outcome, indicating that CD4+ and CD8+ Tregs could be a potential predictive/prognostic biomarker. The study is still opened to accrual and more mature data will be presented at the meeting. Disclosure All authors have declared no conflicts of interest." @default.
- W2999051750 created "2020-01-23" @default.
- W2999051750 creator A5006337734 @default.
- W2999051750 creator A5013237072 @default.
- W2999051750 creator A5014087122 @default.
- W2999051750 creator A5065390944 @default.
- W2999051750 creator A5077410158 @default.
- W2999051750 creator A5080809079 @default.
- W2999051750 date "2012-09-01" @default.
- W2999051750 modified "2023-09-26" @default.
- W2999051750 title "Assessment of the Predictive/ Prognostic Value of the Myeloid-Derived Suppressor Cells (MDSC) and Regulatory T Cells (TREGS) in Non-Small Cell Lung Cancer (NSCLC). Preliminary Results" @default.
- W2999051750 doi "https://doi.org/10.1016/s0923-7534(20)33913-2" @default.
- W2999051750 hasPublicationYear "2012" @default.
- W2999051750 type Work @default.
- W2999051750 sameAs 2999051750 @default.
- W2999051750 citedByCount "0" @default.
- W2999051750 crossrefType "journal-article" @default.
- W2999051750 hasAuthorship W2999051750A5006337734 @default.
- W2999051750 hasAuthorship W2999051750A5013237072 @default.
- W2999051750 hasAuthorship W2999051750A5014087122 @default.
- W2999051750 hasAuthorship W2999051750A5065390944 @default.
- W2999051750 hasAuthorship W2999051750A5077410158 @default.
- W2999051750 hasAuthorship W2999051750A5080809079 @default.
- W2999051750 hasBestOaLocation W29990517501 @default.
- W2999051750 hasConcept C10205521 @default.
- W2999051750 hasConcept C121608353 @default.
- W2999051750 hasConcept C126322002 @default.
- W2999051750 hasConcept C143998085 @default.
- W2999051750 hasConcept C167672396 @default.
- W2999051750 hasConcept C176290653 @default.
- W2999051750 hasConcept C179185449 @default.
- W2999051750 hasConcept C203014093 @default.
- W2999051750 hasConcept C2776090121 @default.
- W2999051750 hasConcept C2776256026 @default.
- W2999051750 hasConcept C2778513237 @default.
- W2999051750 hasConcept C2779727006 @default.
- W2999051750 hasConcept C28328180 @default.
- W2999051750 hasConcept C54355233 @default.
- W2999051750 hasConcept C55721878 @default.
- W2999051750 hasConcept C71924100 @default.
- W2999051750 hasConcept C79484868 @default.
- W2999051750 hasConcept C86803240 @default.
- W2999051750 hasConcept C8891405 @default.
- W2999051750 hasConceptScore W2999051750C10205521 @default.
- W2999051750 hasConceptScore W2999051750C121608353 @default.
- W2999051750 hasConceptScore W2999051750C126322002 @default.
- W2999051750 hasConceptScore W2999051750C143998085 @default.
- W2999051750 hasConceptScore W2999051750C167672396 @default.
- W2999051750 hasConceptScore W2999051750C176290653 @default.
- W2999051750 hasConceptScore W2999051750C179185449 @default.
- W2999051750 hasConceptScore W2999051750C203014093 @default.
- W2999051750 hasConceptScore W2999051750C2776090121 @default.
- W2999051750 hasConceptScore W2999051750C2776256026 @default.
- W2999051750 hasConceptScore W2999051750C2778513237 @default.
- W2999051750 hasConceptScore W2999051750C2779727006 @default.
- W2999051750 hasConceptScore W2999051750C28328180 @default.
- W2999051750 hasConceptScore W2999051750C54355233 @default.
- W2999051750 hasConceptScore W2999051750C55721878 @default.
- W2999051750 hasConceptScore W2999051750C71924100 @default.
- W2999051750 hasConceptScore W2999051750C79484868 @default.
- W2999051750 hasConceptScore W2999051750C86803240 @default.
- W2999051750 hasConceptScore W2999051750C8891405 @default.
- W2999051750 hasLocation W29990517501 @default.
- W2999051750 hasOpenAccess W2999051750 @default.
- W2999051750 hasPrimaryLocation W29990517501 @default.
- W2999051750 hasRelatedWork W1245936448 @default.
- W2999051750 hasRelatedWork W2056515306 @default.
- W2999051750 hasRelatedWork W2188177124 @default.
- W2999051750 hasRelatedWork W2266972208 @default.
- W2999051750 hasRelatedWork W2320455795 @default.
- W2999051750 hasRelatedWork W2362183585 @default.
- W2999051750 hasRelatedWork W2364732263 @default.
- W2999051750 hasRelatedWork W2368386037 @default.
- W2999051750 hasRelatedWork W2371361238 @default.
- W2999051750 hasRelatedWork W2371740653 @default.
- W2999051750 hasRelatedWork W2379196681 @default.
- W2999051750 hasRelatedWork W2381651336 @default.
- W2999051750 hasRelatedWork W2384246362 @default.
- W2999051750 hasRelatedWork W2384253490 @default.
- W2999051750 hasRelatedWork W2389009787 @default.
- W2999051750 hasRelatedWork W2808634849 @default.
- W2999051750 hasRelatedWork W3029041640 @default.
- W2999051750 hasRelatedWork W3030888252 @default.
- W2999051750 hasRelatedWork W3031829407 @default.
- W2999051750 hasRelatedWork W3032714336 @default.
- W2999051750 isParatext "false" @default.
- W2999051750 isRetracted "false" @default.
- W2999051750 magId "2999051750" @default.
- W2999051750 workType "article" @default.